Of the central nervous system tumors and analysis of clinical observation.docVIP

 PAGE \* MERGEFORMAT 7 Of the central nervous system tumors and analysis of clinical observation [Paper Keywords] nervous system; tumor; pathology [Abstract] Objective To investigate the pathological features of the central nervous system tumors. Methods of pathological examination for diagnosis categories include tumor resection or biopsy failure line according to the clinical characteristics of patients, CT and MRI manifestations and diagnostic treatment, clinical diagnostic results according to characteristics of processing of primary nervous system tumors, able to keep as much as possible under the conditions of the nervous system functions of comprehensive treatment. 1 Materials and Methods 1.1 Object selection in January 2008 to August 2009 10 years admitted in neurology patients with primary central nervous system tumors, 163 cases. 1.2 Methods of diagnosis of primary central nervous system tumors diagnosed mainly by pathology, including 75 cases based on CT and MRI diagnostic carried out by patients, but other than non-neoplastic cysts, disease and other cases according to pathology diagnostic criteria, a variety of pathological examination for diagnostic classification. 2 Results 2.1 Types 163 cases of cancer patients, according to the WHO classification of tumors of the central nervous system to craniopharyngioma up, 12.8%, followed by: astrocytoma (12.3%), medulloblastoma accounts for 9.3% of hair cells astrocytoma 7.0%, germ cell tumors account for 5.4%. subependymal giant cell astrocytomas are more common in patients, accounting for 1.3% of different types of tumors, with good nerve anatomy predilection sites. astrocytomas, ependymal cell tumors, neuronal and mixed neuronal tumors seen on the screen simultaneously and the next screen. astrocytic tumors in the brain hemisphere the most common, accounting for 33.2%, followed by cerebellum (27.7 %), third ventricle (11.7%), brainstem (9.2%) and intramedullary spinal cord (5.1%) in